Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The study purpose is to test the hypothesis that Chronic Phase Chronic Myeloid Leukemia (CP-CML) patients with stable Complete Molecular Response (CMR) who discontinue Dasatinib treatment are able to maintain a sustained remission in the long-term, with undetectable or minimally detectable BCR-ABL residual disease.
Inclusion criteria
- Chronic Phase Chronic Myeloid Leukemia